<DOC>
	<DOCNO>NCT00914069</DOCNO>
	<brief_summary>The study test hypothesis RIVS system high rate successful first PIV placement compare conventional catheter without significant increase complication time procedure .</brief_summary>
	<brief_title>Effectiveness Rapid Intravascular Start ( RIVS ) System Versus Conventional Catheter</brief_title>
	<detailed_description>The hypothesis statistically test RIVS system high rate successful first attempt peripheral intravenous placement success compare conventional peripheral intravenous catheter without significant increase device related complication procedure time .</detailed_description>
	<criteria>Inclusion Criteria Any type oncology patient undergo chemotherapy postchemotherapy ( without port/cannula ) , 65 year Requires peripheral IV determine examine physician Requires IV study nurse resident available Able sign inform consent Exclusion Criteria Active systemic cutaneous infection inflammation ; Preexisting immunodeficiency disorder and/or chronic use systemic steroid ; Known , significant history bleed diathesis , coagulopathy , von Willebrand 's disease current platelet count &lt; 100,000 cells/mm3 , baseline INR â‰¥1.8 , fibrinogen level le 150 mg/dl ( receive fibrinolytic agent within prior 24 hour ) ; Currently involve investigational clinical trial ; Previous vascular graft surgery target vessel access site ; Females pregnant , plan become pregnant within 3 month procedure , lactate ; Central line available Requirement immediate IV placement ( patient 's condition would potentially compromised time delay IV placement )</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>